| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |